Related Experiment Videos

[Sedation and analgesia in interventions]

F C de Waal1, J Huisman, A J Veerman

  • 1Afd. Kindergeneeskunde, Academisch Ziekenhuis der Vrije Universiteit, Amsterdam.

Tijdschrift Voor Kindergeneeskunde
|April 1, 1988
PubMed

Insights

Midazolam administered intravenously or rectally shows promise for reducing anxiety and pain in children undergoing medical procedures for leukemia. This medication offers a safe, effective, and short-acting option for pediatric pain management.

Area of Science:

  • Pediatric Oncology
  • Pharmacology
  • Pain Management

Context:

  • Children with leukemia frequently experience significant pain and anxiety during medical procedures such as bone marrow aspiration and lumbar puncture.
  • Current management strategies often involve psychological support, sedative drugs, or general anesthesia, highlighting a need for safer, more effective pharmacological interventions.
  • Minimizing procedural distress is crucial for the well-being and treatment adherence of pediatric patients with leukemia.

Purpose:

  • To explore the potential of midazolam as a safe, short-acting, and effective medication for managing procedural anxiety and pain in children with leukemia.
  • To evaluate the efficacy of intravenous and rectal administration routes for midazolam in this specific pediatric patient population.

Summary:

  • Children with leukemia endure painful procedures, necessitating effective anxiety and pain reduction strategies.
  • Intravenous or rectal administration of midazolam is identified as a promising pharmacological approach.
  • This method offers a potentially safer and more effective alternative to existing sedation or anesthesia techniques.

Impact:

  • Successful implementation of midazolam could significantly improve the patient experience for children undergoing leukemia treatment.
  • This approach may reduce the reliance on general anesthesia, thereby lowering associated risks and healthcare costs.
  • Enhanced pain and anxiety control can contribute to better psychological outcomes and overall quality of life for pediatric cancer patients.

Related Concept Videos